EUROAPI SA (EAPIF)
2.531
-0.10
(-3.76%)
USD |
OTCM |
Jan 16, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 241.00M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -17.01% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.2525 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
| EUROAPI SA engages in manufacturing and supply of active pharmaceutical ingredient solutions for healthcare companies. The company was founded on November 10, 2020, and is headquartered in Gentilly, France. |
| URL | http://www.euroapi.com |
| Investor Relations URL | N/A |
| HQ State/Province | Ile-de-France |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 03, 2026 (est.) |
| Last Earnings Release | Jul. 29, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| EUROAPI SA engages in manufacturing and supply of active pharmaceutical ingredient solutions for healthcare companies. The company was founded on November 10, 2020, and is headquartered in Gentilly, France. |
| URL | http://www.euroapi.com |
| Investor Relations URL | N/A |
| HQ State/Province | Ile-de-France |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 03, 2026 (est.) |
| Last Earnings Release | Jul. 29, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |